External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

SONOMA EYE 2022

-
Coming soon
10:00 AM
Duration 8mins Sonoma, CA
Long-term Efficacy and Safety of Satralizumab▼ in Adults with AQP4-IgG-seropositive Neuromyelitis Optica Spectrum Disorder (NMOSD): Results from the phase 3 SAkura studies
Shervin Gholizadeh

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar